A study of irbesartan 150mg versus 300mg in Chinese hypertensive patients with diabetes and microalbuminuria
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Irbesartan (Primary)
- Indications Diabetic nephropathies; Hypertension; Proteinuria
- Focus Pharmacodynamics
- Sponsors Sanofi
- 06 Nov 2008 Actual patient number (192) added as reported by ClinicalTrials.gov.
- 06 Nov 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
- 06 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.